Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-10-16 Sale | 2023-10-18 4:21 pm | Evolus Inc. | EOLS | Medytox Inc. Former 10% Owner | 1,690,663 | $7.5 | $12,679,973 | 3,381,326 (Direct) | View |
2023-09-06 Sale | 2023-09-08 8:54 pm | Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer | 3,178 | $9.7 | $30,827 | 113,368 (Direct) | View |
2023-08-16 Sale | 2023-08-16 8:25 pm | Evolus Inc. | EOLS | Avelar Rui See Remarks | 2,211 | $10.27 | $22,707 | 353,386 (Direct) | View |
2023-08-16 Sale | 2023-08-16 8:25 pm | Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer | 2,211 | $10.27 | $22,707 | 116,546 (Direct) | View |
2023-08-16 Sale | 2023-08-16 8:25 pm | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 14,778 | $10.27 | $151,770 | 686,592 (Direct) | View |
2023-08-15 Purchase | 2023-08-15 4:34 pm | Evolus Inc. | EOLS | Malik Vikram Director | 174,967 | $7.41 | $1,296,505 | 298,548 (Direct) | View |
2023-03-27 Sale | 2023-03-29 5:11 pm | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 6,110 | $8.47 | $51,752 | 609,567 (Direct) | View |
2023-03-14 Sale | 2023-03-16 7:02 pm | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 64,211 | $8.4689 | $543,797 | 615,677 (Direct) | View |
2023-03-14 Sale | 2023-03-16 7:01 pm | Evolus Inc. | EOLS | Avelar Rui See Remarks | 14,906 | $8.4689 | $126,237 | 335,925 (Direct) | View |
2023-02-17 Sale | 2023-02-22 4:01 pm | Evolus Inc. | EOLS | Alphaeon 1 LLC 10% Owner | 1,850,000 | $8.4 | $15,540,000 | 4,214,871 (Direct) | View |
2023-02-07 Sale | 2023-02-08 8:10 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 2,187,511 | $8.5 | $18,593,844 | 5,071,989 (Direct) | View |
2021-08-12 Purchase | 2023-02-06 4:18 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 37,043 | $11.04 | $408,839 | 7,259,500 (Indirect) | View |
2023-01-20 Sale | 2023-02-06 4:18 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 37,043 | $11.04 | $408,955 | 7,259,500 (Indirect) | View |
2022-10-06 Sale | 2022-10-07 4:12 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 38,304 | $8.9917 | $344,418 | 7,259,500 (Direct) | View |
2022-10-05 Sale | 2022-10-06 4:18 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 6,848 | $8.95 | $61,290 | 7,297,804 (Direct) | View |
2022-09-14 Sale | 2022-09-16 4:10 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 97,000 | $10.29 | $997,778 | 7,304,652 (Direct) | View |
2022-09-09 Purchase | 2022-09-13 5:57 pm | Evolus Inc. | EOLS | HAYMAN ROBERT Director | 10,000 | $10.39 | $103,938 | 49,881 (Indirect Direct) | View |
2022-09-07 Purchase(A) | 2022-09-13 5:57 pm | Evolus Inc. | EOLS | HAYMAN ROBERT Director | 5,000 | $10.05 | $50,250 | 39,881 (Direct) | View |
2022-09-08 Sale | 2022-09-12 5:45 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 36,000 | $10.47 | $376,890 | 7,401,652 (Direct) | View |
2022-09-07 Purchase | 2022-09-09 5:01 pm | Evolus Inc. | EOLS | HAYMAN ROBERT Director | 4,967 | $10.05 | $49,918 | 39,848 (Direct) | View |
2022-09-06 Purchase | 2022-09-08 09:29 am | Evolus Inc. | EOLS | BLANK SIMONE Director | 20,000 | $9.2422 | $184,844 | 422,458 (Indirect Direct) | View |
2022-09-06 Purchase | 2022-09-06 8:03 pm | Evolus Inc. | EOLS | FARRELL PETER C Director | 10,000 | $9.1048 | $91,048 | 44,881 (Indirect Direct) | View |
2022-08-01 Sale | 2022-08-03 4:08 pm | Evolus Inc. | EOLS | Medytox Inc. 10% Owner | 26,000 | $13.28 | $345,361 | 7,437,652 (Direct) | View |
2022-05-16 Sale | 2022-05-18 8:21 pm | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 55,321 | $13.64 | $754,307 | 491,961 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-21 Option Award | 2023-08-23 8:07 pm | N/A 2033-08-21 | Evolus Inc. | EOLS | Yamagishi-Dressler Tomoko Chief Marketing Officer | 146,913 | $0 | 146,913 (Direct) | View |
2023-08-14 Option Award | 2023-08-16 8:25 pm | N/A N/A | Evolus Inc. | EOLS | Avelar Rui See Remarks | 19,672 | $0 | 353,386 (Direct) | View |
2023-08-14 Option Award | 2023-08-16 8:25 pm | N/A N/A | Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer | 19,672 | $0 | 116,546 (Direct) | View |
2023-08-14 Option Award | 2023-08-16 8:25 pm | N/A N/A | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 91,803 | $0 | 686,592 (Direct) | View |
2023-08-11 Other | 2023-08-15 4:34 pm | N/A N/A | Evolus Inc. | EOLS | Malik Vikram Director | 22,998 | $0 | 298,548 (Direct) | View |
2023-08-11 Other | 2023-08-15 4:32 pm | N/A N/A | Evolus Inc. | EOLS | BLANK SIMONE Director | 115,315 | $0 | 661,381 (Direct) | View |
2023-08-11 Other | 2023-08-15 4:32 pm | N/A N/A | Evolus Inc. | EOLS | HAYMAN ROBERT Director | 584 | $0 | 59,342 (Direct) | View |
2023-05-08 Option Award | 2023-05-09 6:21 pm | N/A N/A | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 560,000 | $0 | 560,000 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:42 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Stewart Brady Director | 20,082 | $0 | 56,590 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:42 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | HAYMAN ROBERT Director | 20,082 | $0 | 69,963 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:42 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Malik Vikram Director | 20,082 | $0 | 89,374 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 20,082 | $0 | 54,963 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | BLANK SIMONE Director | 20,082 | $0 | 442,540 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | GILL DAVID N Director | 20,082 | $0 | 49,650 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:40 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | FARRELL PETER C Director | 20,082 | $0 | 64,963 (Direct) | View |
2023-01-25 Option Award | 2023-01-27 7:25 pm | N/A 2033-01-25 | Evolus Inc. | EOLS | Avelar Rui See Remarks | 183,312 | $0 | 436,501 (Direct) | View |
2023-01-25 Option Award | 2023-01-27 7:24 pm | N/A 2033-01-25 | Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks | 444,936 | $0 | 936,897 (Direct) | View |
2023-01-25 Option Award | 2023-01-27 7:24 pm | N/A 2033-01-25 | Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer | 148,312 | $0 | 184,755 (Direct) | View |
2022-09-05 Option Award | 2022-09-06 5:08 pm | N/A 2032-09-05 | Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer | 205,601 | $0 | 205,601 (Direct) | View |